| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
206,773 |
178,950 |
$37.38M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
42,563 |
39,043 |
$7.42M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,749 |
31,912 |
$3.74M |
| 99218 |
|
2,238 |
1,160 |
$3.12M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,776 |
8,632 |
$3.10M |
| 71046 |
Radiologic examination, chest; 2 views |
21,939 |
21,134 |
$2.70M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15,728 |
14,347 |
$2.67M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,084 |
6,780 |
$2.53M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,074 |
9,457 |
$2.52M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
4,117 |
4,011 |
$2.39M |
| 0762 |
|
2,136 |
1,235 |
$1.97M |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,552 |
10,104 |
$1.84M |
| 71045 |
Radiologic examination, chest; single view |
19,121 |
18,153 |
$1.78M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26,890 |
24,793 |
$1.73M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
21,089 |
20,479 |
$1.48M |
| Z7502 |
|
30,705 |
30,224 |
$1.15M |
| 80053 |
Comprehensive metabolic panel |
70,310 |
64,430 |
$1.05M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
16,767 |
15,328 |
$899K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,419 |
3,312 |
$897K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,432 |
1,372 |
$790K |
| 0270 |
|
17,787 |
15,622 |
$789K |
| 93458 |
|
401 |
365 |
$707K |
| 93017 |
|
5,349 |
5,247 |
$645K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
85,949 |
77,226 |
$634K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
8,216 |
7,351 |
$630K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
41,805 |
37,299 |
$625K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,251 |
4,131 |
$606K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,387 |
12,905 |
$533K |
| 0510 |
|
18,743 |
17,628 |
$492K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,630 |
8,913 |
$469K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
3,594 |
3,525 |
$454K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,114 |
14,767 |
$450K |
| J3490 |
Unclassified drugs |
14,562 |
11,408 |
$421K |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,555 |
2,504 |
$405K |
| 76801 |
|
2,620 |
2,325 |
$390K |
| 0360 |
|
2,854 |
2,452 |
$387K |
| Z9725 |
|
8,427 |
8,270 |
$363K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,713 |
6,595 |
$361K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,925 |
7,593 |
$357K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,339 |
5,726 |
$336K |
| 93880 |
|
2,217 |
2,186 |
$331K |
| 73610 |
|
2,745 |
2,692 |
$304K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,095 |
2,021 |
$273K |
| 73630 |
|
2,843 |
2,764 |
$245K |
| 0760 |
|
7,447 |
6,771 |
$232K |
| L8699 |
Prosthetic implant, not otherwise specified |
155 |
135 |
$229K |
| 0121 |
|
50 |
43 |
$229K |
| 73562 |
|
2,384 |
2,296 |
$226K |
| 74018 |
|
2,181 |
2,125 |
$214K |
| 73030 |
|
2,323 |
2,221 |
$210K |
| 73130 |
|
2,169 |
2,106 |
$204K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,918 |
7,596 |
$201K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,088 |
14,561 |
$192K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,315 |
1,263 |
$184K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
25,738 |
22,701 |
$167K |
| 87632 |
|
1,235 |
1,222 |
$146K |
| 73110 |
|
1,399 |
1,350 |
$132K |
| 84484 |
|
17,850 |
15,250 |
$130K |
| 70486 |
|
767 |
749 |
$128K |
| 93296 |
|
8,367 |
8,227 |
$126K |
| 85610 |
|
16,695 |
13,361 |
$125K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,825 |
7,948 |
$121K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,521 |
8,494 |
$120K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
16,172 |
9,538 |
$116K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,063 |
3,839 |
$114K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
127 |
82 |
$111K |
| 0272 |
|
4,664 |
2,612 |
$102K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
315 |
312 |
$99K |
| 83690 |
|
18,794 |
17,512 |
$95K |
| 72100 |
|
916 |
893 |
$95K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
3,975 |
3,833 |
$92K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,203 |
6,128 |
$92K |
| 93971 |
|
1,304 |
1,272 |
$90K |
| 81025 |
|
20,335 |
19,038 |
$89K |
| 83880 |
|
6,060 |
5,647 |
$88K |
| 94060 |
|
683 |
681 |
$88K |
| 73080 |
|
757 |
734 |
$86K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,884 |
1,845 |
$85K |
| 76830 |
Ultrasound, transvaginal |
600 |
581 |
$83K |
| 74022 |
|
492 |
482 |
$82K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
427 |
416 |
$81K |
| 86850 |
|
4,252 |
4,058 |
$79K |
| Q3014 |
Telehealth originating site facility fee |
4,240 |
3,947 |
$79K |
| 73590 |
|
892 |
849 |
$77K |
| 0250 |
|
27,448 |
20,615 |
$76K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,050 |
2,964 |
$76K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,046 |
2,961 |
$75K |
| 81003 |
|
28,280 |
26,806 |
$74K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,756 |
5,588 |
$73K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,155 |
1,120 |
$73K |
| 72131 |
|
341 |
336 |
$73K |
| 36600 |
|
394 |
385 |
$72K |
| 85730 |
|
5,207 |
4,834 |
$71K |
| 73502 |
|
621 |
608 |
$71K |
| 72040 |
|
461 |
445 |
$68K |
| 12001 |
|
355 |
353 |
$65K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12,044 |
11,324 |
$65K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,875 |
2,684 |
$62K |
| 76818 |
|
310 |
233 |
$61K |
| 90715 |
|
1,816 |
1,784 |
$60K |
| 87081 |
|
3,135 |
2,933 |
$59K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,237 |
3,937 |
$57K |
| 76870 |
|
395 |
374 |
$56K |
| 0682 |
|
41 |
39 |
$54K |
| 0761 |
|
1,424 |
1,289 |
$52K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,887 |
3,978 |
$50K |
| 73090 |
|
582 |
561 |
$47K |
| 84702 |
|
5,260 |
4,623 |
$47K |
| 86901 |
|
6,216 |
5,895 |
$46K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,658 |
4,040 |
$46K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,457 |
1,861 |
$45K |
| 86900 |
|
6,216 |
5,894 |
$45K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,681 |
2,972 |
$45K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,126 |
1,550 |
$44K |
| 12002 |
|
233 |
232 |
$43K |
| 10060 |
|
210 |
207 |
$42K |
| 73140 |
|
337 |
328 |
$42K |
| 0710 |
|
2,672 |
2,474 |
$42K |
| 0160 |
|
807 |
433 |
$41K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,435 |
1,278 |
$40K |
| 86140 |
|
10,030 |
9,524 |
$39K |
| 99199 |
Unlisted special service, procedure or report |
756 |
645 |
$38K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,450 |
4,173 |
$38K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,896 |
3,265 |
$37K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,002 |
978 |
$37K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
277 |
261 |
$37K |
| 99215 |
Prolong outpt/office vis |
1,240 |
1,188 |
$35K |
| 29515 |
|
185 |
182 |
$35K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,779 |
6,351 |
$34K |
| 87040 |
|
3,788 |
2,882 |
$34K |
| 85027 |
|
4,890 |
4,548 |
$34K |
| 12011 |
|
172 |
171 |
$33K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
269 |
233 |
$33K |
| 74019 |
|
250 |
241 |
$32K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
226 |
199 |
$31K |
| 87186 |
|
4,076 |
3,793 |
$30K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
830 |
721 |
$30K |
| 94664 |
|
3,435 |
3,108 |
$29K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,884 |
2,268 |
$29K |
| 99205 |
Prolong outpt/office vis |
614 |
606 |
$28K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,404 |
763 |
$27K |
| 81001 |
|
15,126 |
13,838 |
$27K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,569 |
2,485 |
$26K |
| 80047 |
|
2,013 |
1,868 |
$26K |
| J2704 |
Injection, propofol, 10 mg |
1,496 |
1,431 |
$26K |
| 82550 |
|
6,819 |
6,054 |
$25K |
| 94726 |
|
261 |
261 |
$25K |
| 96376 |
|
323 |
267 |
$24K |
| 59025 |
Fetal non-stress test |
1,003 |
767 |
$24K |
| 82247 |
|
1,653 |
1,362 |
$23K |
| 82962 |
|
8,971 |
5,224 |
$22K |
| 82553 |
|
4,674 |
4,048 |
$22K |
| 83605 |
|
2,533 |
2,255 |
$22K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,640 |
3,450 |
$21K |
| 83735 |
|
4,321 |
3,776 |
$21K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
683 |
637 |
$19K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
2,277 |
1,837 |
$19K |
| 94729 |
|
261 |
261 |
$19K |
| 87077 |
|
4,077 |
3,795 |
$18K |
| 93299 |
|
929 |
916 |
$18K |
| 93970 |
|
123 |
119 |
$17K |
| 71020 |
|
596 |
300 |
$16K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
922 |
731 |
$16K |
| 0300 |
|
855 |
811 |
$15K |
| 72128 |
|
29 |
29 |
$15K |
| 0320 |
|
393 |
385 |
$14K |
| 82248 |
|
1,062 |
933 |
$14K |
| 93226 |
|
379 |
378 |
$13K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
60 |
55 |
$12K |
| 73560 |
|
100 |
96 |
$11K |
| Z7610 |
|
868 |
843 |
$11K |
| 0271 |
|
2,179 |
2,022 |
$11K |
| 84145 |
|
743 |
734 |
$11K |
| J2060 |
Injection, lorazepam, 2 mg |
1,391 |
1,263 |
$11K |
| 76770 |
|
62 |
60 |
$11K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,720 |
1,586 |
$10K |
| 93225 |
|
412 |
411 |
$10K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
89 |
40 |
$10K |
| 70360 |
|
61 |
52 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
53 |
51 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,741 |
1,683 |
$8K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
275 |
271 |
$8K |
| 29130 |
|
31 |
30 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
193 |
193 |
$7K |
| 73564 |
|
41 |
41 |
$7K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
534 |
501 |
$7K |
| 70491 |
|
30 |
26 |
$6K |
| 73552 |
|
59 |
58 |
$6K |
| 85379 |
|
965 |
920 |
$6K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
550 |
504 |
$6K |
| 84439 |
|
731 |
718 |
$6K |
| 0255 |
|
74 |
74 |
$6K |
| 85652 |
|
2,805 |
2,696 |
$6K |
| 73660 |
|
40 |
40 |
$6K |
| 81002 |
|
2,817 |
2,300 |
$5K |
| 80061 |
Lipid panel |
647 |
601 |
$5K |
| 86780 |
|
625 |
616 |
$5K |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
17 |
17 |
$5K |
| 0002A |
|
132 |
132 |
$5K |
| 94644 |
|
528 |
443 |
$5K |
| 0001A |
|
136 |
136 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
364 |
173 |
$5K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
674 |
591 |
$4K |
| 29105 |
|
25 |
25 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13 |
12 |
$4K |
| 71010 |
|
236 |
101 |
$4K |
| 72072 |
|
37 |
37 |
$4K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
27 |
25 |
$4K |
| 71101 |
|
25 |
24 |
$3K |
| 82731 |
|
235 |
217 |
$3K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
274 |
260 |
$3K |
| 0370 |
|
824 |
788 |
$3K |
| 70496 |
|
15 |
14 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
84 |
83 |
$3K |
| 96367 |
|
118 |
105 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
180 |
180 |
$3K |
| 93925 |
|
26 |
25 |
$3K |
| 72170 |
|
71 |
71 |
$3K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
12 |
12 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
428 |
392 |
$2K |
| 73060 |
|
37 |
37 |
$2K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$2K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
90 |
61 |
$2K |
| 70498 |
|
15 |
14 |
$2K |
| 82140 |
|
274 |
256 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
150 |
131 |
$2K |
| 84550 |
|
686 |
594 |
$2K |
| 83518 |
|
315 |
274 |
$2K |
| 85384 |
|
327 |
269 |
$2K |
| Z7500 |
|
51 |
51 |
$2K |
| 86923 |
|
16 |
13 |
$2K |
| J2359 |
Injection, olanzapine, 0.5 mg |
40 |
37 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
119 |
73 |
$1K |
| 74000 |
|
41 |
21 |
$1K |
| 86403 |
|
200 |
155 |
$1K |
| 87070 |
|
279 |
262 |
$1K |
| 99070 |
|
47 |
39 |
$1K |
| 87210 |
|
581 |
556 |
$1K |
| 85362 |
|
180 |
151 |
$1K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
50 |
50 |
$1K |
| A4217 |
Sterile water/saline, 500 ml |
157 |
89 |
$970.85 |
| 86703 |
|
188 |
177 |
$881.69 |
| 97161 |
|
44 |
43 |
$845.81 |
| 29125 |
|
130 |
125 |
$797.86 |
| 81015 |
|
141 |
138 |
$793.86 |
| 94760 |
|
226 |
106 |
$777.90 |
| 84100 |
|
308 |
247 |
$709.63 |
| 82570 |
|
180 |
157 |
$641.87 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
350 |
216 |
$640.04 |
| 0031A |
|
15 |
15 |
$600.00 |
| 86592 |
|
348 |
339 |
$591.84 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
31 |
31 |
$562.77 |
| 87486 |
|
28 |
28 |
$548.69 |
| 87581 |
|
28 |
28 |
$548.69 |
| 87506 |
|
13 |
13 |
$511.20 |
| 93922 |
|
13 |
13 |
$467.52 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
68 |
65 |
$446.54 |
| 80076 |
|
124 |
110 |
$435.79 |
| A9270 |
Non-covered item or service |
303 |
286 |
$423.13 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
14 |
12 |
$414.84 |
| J1940 |
Injection, furosemide, up to 20 mg |
51 |
41 |
$382.23 |
| 83615 |
|
36 |
36 |
$374.89 |
| 84156 |
|
150 |
130 |
$328.79 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
13 |
$315.00 |
| 82728 |
|
24 |
24 |
$297.11 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
34 |
28 |
$215.80 |
| 94010 |
|
12 |
12 |
$204.30 |
| 87147 |
|
82 |
74 |
$171.67 |
| 84132 |
|
16 |
12 |
$153.64 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
20 |
16 |
$152.37 |
| 29505 |
|
37 |
37 |
$129.67 |
| J1953 |
Injection, levetiracetam, 10 mg |
13 |
12 |
$110.27 |
| 0258 |
|
139 |
132 |
$106.40 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
16 |
15 |
$76.88 |
| 86308 |
|
28 |
28 |
$67.48 |
| 62370 |
|
14 |
13 |
$58.00 |
| 0420 |
|
79 |
79 |
$0.00 |
| 0350 |
|
96 |
96 |
$0.00 |
| 99441 |
|
29 |
18 |
$0.00 |
| 0440 |
|
12 |
12 |
$0.00 |
| 0730 |
|
100 |
100 |
$0.00 |
| 0430 |
|
12 |
12 |
$0.00 |